Affiliation:
1. Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill 27599.
Abstract
A specific interleukin-1 (IL-1) receptor antagonist (IL-1ra) was used to examine the roles of IL-1 in an experimental model designed to analyze the reactivation phase of erosive arthritis, induced in rats with peptidoglycan-polysaccharide polymers (PG-APS) isolated from cell walls of group A streptococci. Monoarticular arthritis was initiated by injection of a small dose of PG-APS into an ankle joint, and reactivation was induced by intravenous injection of PG-APS 20 days later. Human recombinant IL-1ra given at a dose of 2 to 3 mg/kg at the time of reactivation of arthritis and at 6-h intervals inhibits the increase in joint swelling by at least 60%. Joint swelling is suppressed 30 to 50% when the initial treatment with IL-1ra is delayed until 6 h after reactivation. IL-1ra is not effective when the initial injection is delayed 12 or 24 h. With an injection schedule of IL-1ra given at the time of reactivation and every 6 h, treatment can be stopped at 24 h and the suppression of swelling is no different from that in rats for which injections are continued for 4 days. The results indicate that IL-1 has a prominent, although not exclusive, role in initiating inflammation in this model and is involved in the amplifying processes in progressive inflammation and chronic erosive disease. An anti-inflammatory function of IL-1 is also indicated from data showing that IL-1ra treatment limited to 6 h or less after the induction of reactivation enhances joint swelling, whereas intravenous injection of human recombinant IL-1 beta 24 h before reactivation suppresses the reactivation of arthritis.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Immunology,Microbiology,Parasitology
Reference31 articles.
1. Effects of immune complexes on production by human monocytes of interleukin 1 or an interleukin 1 inhibitor;Arend W. P.;J. Immunol.,1985
2. An IL-1 inhibitor from human monocytes: production and characterization of biologic properties;Arend W. P.;J. Immunol.,1989
3. Biological properties of recombinant human monocyte-derived IL-1 receptor antagonist;Arend W. P.;J. Clin. Invest.,1990
4. Evidence for different interleukin 1 receptors in murine B- and T-cell lines;Bomsztyk K.;Proc. Natl. Acad. Sci. USA,1989
5. Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein;Carter D. B.;Nature (London),1990
Cited by
149 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献